non-IgG therapeutic antibodies for Pancreas Carcinoma

Bellasmith121 Dec, 2022News

Non-IgG isotype has become an alternative to conventional IgG for the clinical diagnosis and treatment of tumors. Equipped with the world-leading antibody development platform and professional scientific staffs, Creative Biolabs is dedicated to developing and utilizing the non-IgG therapeutic antibodies (mainly IgM) as promising treatments for pancreas carcinoma. Currently, we are able to provide one-stop non-IgG development services extended from antibody production and purification to characterization and modification.